Abstract: A container handling system includes first and second rotary machines each comprising transport elements for transporting containers along first and second conveying paths, where the second conveying path is downstream of the first conveying path, a memory device, and a control device configured to determine during transport of a container that first and second transport elements transport containers in the first and second rotary machines and to store identifiers assigned to the first and second transport elements in the memory device, to ascertain whether an error is occurring during transport of the container through the container handling system, and to retrieve a stored identifier from the memory device if it is ascertained that the error has occurred.

Abstract: Method for forming plastic preforms into plastic containers, wherein a plastic preform is introduced into a blow mould and is expanded into a plastic container by being applied by a flowable medium, wherein the plastic preform is applied by at least two different pressure levels and wherein furthermore preferably a rod-like body is introduced into the plastic preform, in order to expand the plastic preform in its longitudinal direction, wherein a pressure curve and/or a movement curve of the rod-like body being determined by a measuring device during the expansion process, wherein least one of the curves is evaluated by means of a processor device and at least one point or region of this curve which is characteristic of the course is determined.

Abstract: Methods and compositions for inducing penile erections, sufficient for vaginal penetration, in a human male suffering from impotence are provided. Kits containing the compositions in containers for single dosage administration are provided.Compositions for treating impotence that is of psychogenic or neurogenic origin contain a neuropeptide, vasoactive intestinal peptide and/or peptide N-terminal histidine C-terminal methioneamide and are formulated in a pharmaceutically acceptable carrier that has a pH of about 2 to about 4.5, preferably between about 2 and about 3.5, and most preferably about 3. Compositions for treating impotence of almost origin, including severe atherosclerosis, contain a neuropeptide, vasoactive intestinal peptide and/or peptide N-terminal histidine C-terminal methioneamide, and an .alpha.-adrenergic blocker, such as phentolamine or prazosin.In practicing the methods, the composition is administered by intracavernosal injection accompanied by or followed by sexual stimulation.

Abstract: The present invention provides methods and compositions for inducing penile erections, sufficient for vaginal penetration, in a human male suffering from impotence. When the impotence is substantially only neurogenic, psycogenic or neurogenic and psychogenic, a method of the invention comprises (A) administering to the male by intracavernosal injection peptide N-terminal histidine C-terminal methionineamide and (B) sexually stimulating the male. When the impotence is caused by severe atherosclerosis, a method of the invention comprises (A) administering to the male by intracavernosal injection an amount of a physiologically acceptable composition comprising (1) a neuropeptide selected from the group consisting of human vasoactive intestinal peptide and peptide N-terminal histidine C-terminal methionineamide and (2) an alpha-adrenergic blocker, such as phentolamine or prazosin, and (B) sexually stimulating the male.